Skip to main content
Fig. 3 | Arthritis Research & Therapy

Fig. 3

From: Matrix metalloproteinase-3 and the 7-joint ultrasound score in the assessment of disease activity and therapeutic efficacy in patients with moderate to severe rheumatoid arthritis

Fig. 3

Matrix metalloproteinase-3 (MMP-3) and 7-joint ultrasound (US7) scores in 22 patients with rheumatoid arthritis (RA) after treatment with certolizumab pegol (CZP). US7 scores were compared between the MMP-3-positive and the MMP-3-negative groups. Patients’ MMP-3 levels and US7 scores were significantly decreased at week 2 compared with baseline levels

Back to article page

Arthritis Research & Therapy

ISSN: 1478-6362

Contact us